Home  >  Products  >  RALBP1 (ralA binding protein 1) Blocking Peptide (the N terminal of RALBP1)(100ug)
RALBP1 (ralA binding protein 1) Blocking Peptide (the N terminal of RALBP1)(100ug)

RALBP1 (ralA binding protein 1) Blocking Peptide (the N terminal of RALBP1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RALBP1 Antibody(ARP52251_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP52251
Size: 100ug
Weight: 76kDa
Gene: 10928
Format: Lyophilized powder
Target: RALBP1 can activate specifically hydrolysis of GTP bound to RAC1 and CDC42, but not RALA. RALBP1 mediates ATP-dependent transport of S-(2,4-dinitrophenyl)-glutathione (DNP-SG) and doxorubicin (DOX) and is the major ATP-dependent transporter of glutathione conjugates of electrophiles (GS-E) and DOX in erythrocytes.RALBP1 can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon. RALBP1 serves as a scaffold protein that brings together proteins forming an endocytotic complex during interphase and also with CDK1 to switch off endocytosis, One of its substrates would be EPN1/Epsin.
Alternative names: RIP; RIP1; RLIP76
See Full Product Listings >